Drawing for IDM PHARMA

USPTO serial 77007757

IDM PHARMA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DINALLO, KEVIN M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IDM PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kent M. Walker,

KENT M. WALKER, COOLEY GODWARD LLP777 6TH STREET, NWSUITE 1100WASHINGTON, DC 20001-2421

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in science and research, namely, diagnostic preparations, cellular preparations, cells, culture media, and cellular culture, all for scientific and research useACTIVE—
005Chemical, pharmaceutical and veterinary preparations and products used for biomedical, clinical and therapy purposes, namely, diagnostic preparations, cellular preparations, cells, culture media, and cellular culture, all for clinical, biomedical, cell therapy, anti-cancer therapy and veterinary useACTIVE—
042Scientific research services, namely, basic and applied scientific research services in the biomedical, agrifood, agricultural and cellular therapy and cell preparation fields; quality control services for others; medical and chemical laboratories in the field of cell preparation and pharmaceutical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 28, 2009MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 28, 2009ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 29, 2009CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 21, 2009MAILPAPER RECEIVED—
Feb 14, 2009EX2GSOU EXTENSION 2 GRANTED—
Feb 12, 2009EXT2SOU EXTENSION 2 FILED—
Feb 12, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 21, 2008EX1GSOU EXTENSION 1 GRANTED—
Aug 21, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 12, 2008EXT1SOU EXTENSION 1 FILED—
Aug 12, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 26, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 4, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 14, 2007NPUBNOTICE OF PUBLICATION—
Oct 26, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 26, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 26, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Oct 26, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 26, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 26, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 19, 2007ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 1, 2007PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 20, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 20, 2007ALIEASSIGNED TO LIE—
Aug 15, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 14, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 14, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 14, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2007DOCKASSIGNED TO EXAMINER—
Oct 2, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance